Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nancy A. Simonian currently holds 6,000 shares of Syros Pharmaceuticals, Inc. (SYRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy A. Simonian has been a net seller of SYRS stock. They have purchased $0 and sold $2.1M worth of shares.
Nancy A. Simonian's most recent insider trade was on Oct 31, 2024, when they sold 40,125 shares at $0.00 per share.
Nancy A. Simonian serves as Executive at Syros Pharmaceuticals, Inc. (SYRS). They have executed 54 insider transactions totaling $2.1M over their tenure at the company.
Nancy A. Simonian holds the position of Executive at Syros Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Nancy A. Simonian has shown a selling trading pattern, with $0 in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nancy A. Simonian was on Dec 14, 2023, when they sold $14.4M worth of SGEN shares. This transaction involved 62,753 shares at $229.00 per share.
Nancy A. Simonian currently owns 6,000 shares of Syros Pharmaceuticals, Inc. (SYRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nancy A. Simonian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nancy A. Simonian has 54 Form 4 filings on record as an insider at Syros Pharmaceuticals, Inc..
Set alerts for Nancy A. Simonian and 40,000+ other insiders.